Veterinary Medicines

Weravet 6 Keratisal

Authorised
  • EUPHRASIA C30
  • ATROPA BELLA-DONNA C30
Download as PDF

Product identification

Medicine name:
Weravet 6 Keratisal
Active substance:
  • EUPHRASIA C30
  • ATROPA BELLA-DONNA C30
Target species:
  • Cattle
  • Dog
  • Goat
  • Sheep
  • Horse
  • Cat
  • Pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • EUPHRASIA C30
    199.10
    milligram(s)
    /
    2.00
    millilitre(s)
  • ATROPA BELLA-DONNA C30
    199.10
    milligram(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cat
    • Pig
      • Meat and offal
        0
        day
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Dr. Assmann Veterinaerspezialitaeten GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biokanol Pharma GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6158273.00.00
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."